Are you Dr. Eary?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 36 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Uab Medical Center Jt N412
Birmingham, AL 35249Phone+1 205-934-3138- Is this information wrong?
Summary
- Dr. Janet Eary, MD is a board certified nuclear medicine physician in Birmingham, Alabama. She is currently licensed to practice medicine in Alabama, Michigan, and Washington. She is affiliated with Seattle Children's Hospital, UW Medicine/University of Washington Medical Center, and Mann-Grandstaff Department of Veterans Affairs Medical Center.
Education & Training
University of WashingtonResidency, Nuclear Medicine, 1983 - 1986- University of WashingtonResidency, Pathology-Anatomic and Clinical, 1980 - 1983
Michigan State University College of Human MedicineClass of 1980
Certifications & Licensure
WA State Medical License 1981 - 2024
MI State Medical License 2013 - 2017
AL State Medical License 2013 - 2016- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
Clinical Trials
- F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer Start of enrollment: 2008 Sep 01
- 18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma Start of enrollment: 2010 Feb 01
- F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy Start of enrollment: 2010 Sep 15
Publications & Presentations
PubMed
- 10 citationsPredictors ofF-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy.Mena, E., Rowe, S., Shih, J., Lindenberg, L., Turkbey, B., Fourquet, A., Lin, F., Adler, S., Eclarinal, P., McKinney, Y., Citrin, D., Dahut, W., Wood, B., Chang, R., L...> ;Journal of Nuclear Medicine. 2022 Aug 1
- 13 citations18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer.Lanell M. Peterson, Brenda F. Kurland, Fengting Yan, Alena Novakova Jiresova, Vijayakrishna K. Gadi, Jennifer M. Specht, Julie R. Gralow, Erin K. Schubert, Jeanne M. L...> ;Journal of Nuclear Medicine. 2021 Feb 1
- 1 citationsCancer Imaging Program Update: 2020.Janet F. Eary> ;Radiology. Imaging Cancer. 2020 Jul 31
- Join now to see all
Press Mentions
New Nuclear-Imaging Tests Show Promise in Locating CancerSeptember 25th, 2016
Grant Support
- Molecular Imaging Of Cancer And Its Response To TherapyNational Cancer Institute2011
- PET In Sarcoma - A Clinical TrialNational Cancer Institute2006–2011
- Lymphoma And Its Response To TreatmentNational Cancer Institute2004–2008
- Early Clinical Trials Of Imaging AgentsNational Cancer Institute2007
- PET In Sarcoma--A Clinical TrialNational Cancer Institute1995–2005
- Core--RadiochemistryNational Cancer Institute2000–2002
- Quantitation Of Tumor Growth In Novel Cancer TherapiesNational Cancer Institute1998–2002
- Radiolabelled Antibody Biodistribution, Internal Dosimetry/RadiotherapyNational Cancer Institute1995–1999
- Radiochemistry--CoreNational Cancer Institute1991–1999
- Determination Of Estrogen Receptor Content In Breast Cancer By PETNational Cancer Institute1996–1997
- Quantitation Of Radiolabeled Antibody DistributionNational Cancer Institute1989–1993
Hospital Affiliations
Seattle Children's HospitalSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
Mann-Grandstaff Department of Veterans Affairs Medical CenterSpokane, Washington
Seattle VA Medical CenterSeattle, Washington
